Compare Direxion Daily Semiconductor Bear 3X Shares (SOXS) vs 10X Genomics Inc (TXG) Price & Performance

SOXS, the Direxion Daily Semiconductor Bear 3X ETF, trades at $53.99, down 1.64% today, reflecting its inverse leveraged exposure to semiconductor stocks. Technical indicators show a bullish moving average signal but bearish oscillators with RSI levels above 96 suggesting extreme overbought conditions. Recent news highlights SOXS surging during semiconductor sell-offs, with a 1:10 stock split scheduled for July 26, 2026. The fund is designed for short-term tactical trades amid sector volatility.

The outlook for SOXS remains highly speculative, offering potential gains during semiconductor downturns but carrying significant decay and volatility risks. Investors should be cautious as the ETF is not suitable for long-term holdings due to its daily reset structure and inverse leverage, which can lead to substantial losses in rising markets.

TXG trades at $43.18, down 1.28% today, with a bullish technical signal and positive earnings momentum. The stock shows improving fundamentals with revenue growth to $642.82M in 2025 and narrowing losses, while maintaining a strong gross margin of 69.6%. Recent acquisitions and partnerships with Cleveland Clinic demonstrate strategic expansion in genomic diagnostics.

The outlook remains cautiously optimistic with analyst consensus at Buy (45%) and price target of $39.14. Key risks include continued negative profitability metrics and high valuation multiples, while catalysts include upcoming Q2 2026 earnings and platform adoption growth.